Kumagai, Erina, Mano, Yohei, Yoshio, Sachiyo, Shoji, Hirotaka, Sugiyama, Masaya, Korenaga, Masaaki, Ishida, Tsuyoshi, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Kawaguchi, Takumi, Torimura, Takuji, Nozaki, Yuichi, Watanabe, Sumio, Mizokami, Masashi, Kanto, Tatsuya (2016) Serum YKL-40 as a marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports, 6. doi:10.1038/srep35282

See Also

These are possibly similar items as determined by title/reference text matching only.

	Shoji, Hirotaka, Yoshio, Sachiyo, Mano, Yohei, Kumagai, Erina, Sugiyama, Masaya, Korenaga, Masaaki, Arai, Taeang, Itokawa, Norio, Atsukawa, Masanori, Aikata, Hiroshi, Hyogo, Hideyuki, Chayama, Kazuaki, Ohashi, Tomohiko, Ito, Kiyoaki, Yoneda, Masashi, Nozaki, Yuichi, Kawaguchi, Takumi, Torimura, Takuji, Abe, Masanori, Hiasa, Yoichi, Fukai, Moto, Kamiyama, Toshiya, Taketomi, Akinobu, Mizokami, Masashi, Kanto, Tatsuya (2016) Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease. Scientific Reports, 6. doi:10.1038/srep28814
	Sumida, Yoshio, Yoneda, Masashi, Tokushige, Katsutoshi, Kawanaka, Miwa, Fujii, Hideki, Yoneda, Masato, Imajo, Kento, Takahashi, Hirokazu, Eguchi, Yuichiro, Ono, Masafumi, Nozaki, Yuichi, Hyogo, Hideyuki, Koseki, Masahiro, Yoshida, Yuichi, Kawaguchi, Takumi, Kamada, Yoshihiro, Okanoue, Takeshi, Nakajima, Atsushi, Japan Study Group of NAFLD (JSG-NAFLD), (2021) FIB-4 First in the Diagnostic Algorithm of Metabolic-Dysfunction-Associated Fatty Liver Disease in the Era of the Global Metabodemic. Life, 11 (2) 143 doi:10.3390/life11020143
	Kawano, Tadamichi, Atsukawa, Masanori, Tsubota, Akihito, Shimada, Noritomo, Toyoda, Hidenori, Takaguchi, Koichi, Tani, Joji, Morishita, Asahiro, Hiraoka, Atsushi, Mikami, Shigeru, Ishikawa, Toru, Okubo, Hironao, Watanabe, Tsunamasa, Okubo, Tomomi, Arai, Taeang, Hayama, Korenobu, Itokawa, Norio, Kondo, Chisa, Iwakiri, Katsuhiko (2022) Shorter pruritus period and milder disease stage are associated with response to nalfurafine hydrochloride in patients with chronic liver disease. Scientific Reports, 12 (1) doi:10.1038/s41598-022-11431-1
	Kawaguchi, Takumi, Tokushige, Katsutoshi, Hyogo, Hideyuki, Aikata, Hiroshi, Nakajima, Tomoaki, Ono, Masafumi, Kawanaka, Miwa, Sawada, Koji, Imajo, Kento, Honda, Koichi, Takahashi, Hirokazu, Mori, Kohjiroh, Tanaka, Saiyu, Seko, Yuya, Nozaki, Yuichi, Kamada, Yoshihiro, Fujii, Hideki, Kawaguchi, Atsushi, Takehara, Tetsuo, Yanase, Mikio, Sumida, Yoshio, Eguchi, Yuichiro, Seike, Masataka, Yoneda, Masato, Suzuki, Yasuaki, Saibara, Toshiji, Karino, Yoshiyasu, Chayama, Kazuaki, Hashimoto, Etsuko, George, Jacob, Torimura, Takuji (2018) A Data Mining-based Prognostic Algorithm for NAFLD-related Hepatoma Patients: A Nationwide Study by the Japan Study Group of NAFLD. Scientific Reports, 8. doi:10.1038/s41598-018-28650-0
	Hashida, Ryuki, Nakano, Dan, Yamamura, Sakura, Kawaguchi, Takumi, Tsutsumi, Tsubasa, Matsuse, Hiroo, Takahashi, Hirokazu, Gerber, Lynn, Younossi, Zobair M., Torimura, Takuji (2021) Association between Activity and Brain-Derived Neurotrophic Factor in Patients with Non-Alcoholic Fatty Liver Disease: A Data-Mining Analysis. Life, 11 (8) 799 doi:10.3390/life11080799
	Nishitsuji, Hironori, Ujino, Saneyuki, Yoshio, Sachiyo, Sugiyama, Masaya, Mizokami, Masashi, Kanto, Tatsuya, Shimotohno, Kunitada (2016) Long noncoding RNA #32 contributes to antiviral responses by controlling interferon-stimulated gene expression. Proceedings of the National Academy of Sciences, 113 (37) 10388-10393 doi:10.1073/pnas.1525022113
	Sumida, Yoshio, Yoneda, Masashi, Tokushige, Katsutoshi, Kawanaka, Miwa, Fujii, Hideki, Yoneda, Masato, Imajo, Kento, Takahashi, Hirokazu, Eguchi, Yuichiro, Ono, Masafumi, Nozaki, Yuichi, Hyogo, Hideyuki, Koseki, Masahiro, Yoshida, Yuichi, Kawaguchi, Takumi, Kamada, Yoshihiro, Okanoue, Takeshi, Nakajima, Atsushi, , (2020) Antidiabetic Therapy in the Treatment of Nonalcoholic Steatohepatitis. International Journal of Molecular Sciences, 21. 1907pp. doi:10.3390/ijms21061907
	Kuno, Atsushi, Ikehara, Yuzuru, Tanaka, Yasuhito, Ito, Kiyoaki, Matsuda, Atsushi, Sekiya, Satoru, Hige, Shuhei, Sakamoto, Michiie, Kage, Masayoshi, Mizokami, Masashi, Narimatsu, Hisashi (2013) A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis. Scientific Reports, 3. doi:10.1038/srep01065
	Wang, Baohong, Jiang, Xiangyang, Cao, Min, Ge, Jianping, Bao, Qiongling, Tang, Lingling, Chen, Yu, Li, Lanjuan (2016) Altered Fecal Microbiota Correlates with Liver Biochemistry in Nonobese Patients with Non-alcoholic Fatty Liver Disease. Scientific Reports, 6. doi:10.1038/srep32002
	Ochi, Tsunehiro, Kawaguchi, Takumi, Nakahara, Takashi, Ono, Masafumi, Noguchi, Shuhei, Koshiyama, Yuichi, Munekage, Kensuke, Murakami, Eisuke, Hiramatsu, Akira, Ogasawara, Mitsunari, Hirose, Akira, Mizuta, Hiroshi, Masuda, Kosei, Okamoto, Nobuto, Suganuma, Narufumi, Chayama, Kazuaki, Yamaguchi, Masahiro, Torimura, Takuji, Saibara, Toshiji (2017) Differences in characteristics of glucose intolerance between patients with NAFLD and chronic hepatitis C as determined by CGMS. Scientific Reports, 7. doi:10.1038/s41598-017-09256-4
	Yang, Xinyi, Lin, Yan, Huang, Jiaofeng, Chi, Yujing, Wu, Yinlian, Lin, Su (2024) Serum uric acid levels and prognosis of patients with non-alcoholic fatty liver disease. Scientific Reports, 14 (1) doi:10.1038/s41598-024-55845-5